Table 2 Results of Ov-16 IgG4 antibody prevalence in children by age in 2017
Age | Number of children tested | Number of children positive by the first test | Number of children confirmed positive by the second test | Prevalence (%) (95% CI)a |
|---|---|---|---|---|
4 | 5 | 0 | 0 | (–) |
5 | 1703 | 14 | 13 | 0.8 (0.5–1.3) |
6 | 3550 | 42 | 38 | 1.1 (0.8–1.5) |
7 | 3232 | 64 | 59 | 1.8 (1.4–2.4) |
8 | 3161 | 78 | 72 | 2.3 (1.8–2.9) |
9 | 2584 | 56 | 54 | 2.1 (1.6–2.7) |
10 | 1782 | 56 | 54 | 3.0 (2.3–3.9) |
11 | 586 | 20 | 20 | 3.4 (2.2–5.2) |
12 | 511 | 21 | 20 | 3.9 (2.6–6.0) |
13 | 174 | 8 | 8 | 4.6 (2.4–8.8) |
14 | 76 | 8 | 8 | 10.5 (5.4–19.4) |
(15–19)b | (34) | (1) | (1) | (–) |
(–)b | (4) | (0) | (0) | (–) |
Total | 17,364 | 367 | 346 | 2.0 (1.8–2.2) |